Literature DB >> 12205726

Countertransference management and therapy outcome: an initial evaluation.

Charles J Gelso1, Mara G Latts, Maria J Gomez, Ruth E Fassinger.   

Abstract

The relationship between therapist countertransference management ability and therapy outcome was examined. Participants were 32 therapist-trainees and their clinical supervisors. Supervisors completed the Countertransference Factors Inventory (CFI) with regard to their supervisees. The CFI assesses five therapist characteristics thought to comprise countertransference management: Self-Insight, Self-Integration, Anxiety Management, Empathy, and Conceptualizing Skills. Both trainees and their supervisors rated the degree of improvement for each client seen in therapy. Results indicated that the CFI total score and the subscales of Anxiety Management and Conceptualizing Skills were positively related to both trainee and supervisor ratings of outcome; Self-Integration was related to trainee, but not supervisor, outcome ratings. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12205726     DOI: 10.1002/jclp.2010

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  3 in total

1.  Countertransference in child and adolescent psychiatry-a forgotten concept?

Authors:  Daniel Rasic
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-11

2.  Distinctive emotional responses of clinicians to suicide-attempting patients--a comparative study.

Authors:  Zimri S Yaseen; Jessica Briggs; Irina Kopeykina; Kali M Orchard; Jessica Silberlicht; Hetal Bhingradia; Igor I Galynker
Journal:  BMC Psychiatry       Date:  2013-09-22       Impact factor: 3.630

3.  Therapists' emotional state after sessions in which suicidality is addressed: need for improved management of suicidal tendencies in patients with borderline personality pathology.

Authors:  Vera Bühlmann; Susanne Schlüter-Müller; Lukas Fürer; Martin Steppan; Marc Birkhölzer; Klaus Schmeck; Julian Koenig; Michael Kaess; Ronan Zimmermann
Journal:  BMC Psychiatry       Date:  2021-11-23       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.